Injective ETF Secures Nasdaq Listing Approval Under INJC Ticker
Photo: The Coin Republic
Key Insights: Injective ETF receives Nasdaq listing approval under INJC; trading awaits an effective S-1. Canary Capital plans to stake at least 90% of INJ holdings, with BitGo providing custody. The INJ price was reported near $7.64, with $7.30 support and 8.00–8.20 targets in focus. Canary Capital has secured Nasdaq listing approval for its Staked Injective ETF, according to a November 3 SEC filing . The fund plans to trade under INJC, although public sales must wait until its S-1 registration becomes effective.
Source: The Coin Republic
